chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MMR
Symptoms: Eye irritation, Medication error
Clinical narrative: Information has been received from a registered nurse concerning a white female patient who's child was vaccinated with MMR. Subsequently, the vaccine splashed into mother's eye while she was holding the child. The mother complained of burning and the eye was washed out. No additional information was available. Follow up information indicated on 12/16/04 at 14:30 the child was receiving the vaccine and the needle came off the needle hub and splashed the mother in the eye with vaccine. Her right eye was irrigated immediately. She complained of slight burning and it was irrigated again. No burning, redness, or swelling was noted. Follow up the next day indicated no problems. The patient recovered. No further information is expected.
Age: 1.05
Sex: M
Vaccine: DTP, FLUX, HIBV, MMR, VARCEL
Symptoms: Diarrhoea, Erythema, Furuncle, Pyrexia, Roseola
Clinical narrative: Information has been received from a physician concerning a 12 month old white male patient with otitis media and upper respiratory tract infection who on 12/12/04 was vaccinated SC with a dose of MMR. Secondary concomitant vaccination on 12/12/04 included a dose of varicella virus vaccine live, diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid, influenza virus vaccine, HIB conjugate vaccine. Concomitant medication included prednisolone Na phosphate and budesonide. On 12/12/04, the patient experienced fever (from 101-103.7 degrees F), foam at mouth, 6 areas of redness and boil left thigh. The patient came to the office on 12/14/04 and was treated with cephalexin. On 12/17/04 the patient experienced foamy loose stool. On 12/20/04 the patient experienced roseola described as a rash all over. It was reported that the patient had recovered from the roseola, the boil, the areas of redness, the fever, and the foamy loose stools and the foaming at the mouth. Additional information is not expected.
Age: 1.05
Sex: M
Vaccine: DTP, FLUX, HIBV, MMR, VARCEL
Symptoms: Salivary hypersecretion
Clinical narrative: Information has been received from a physician concerning a 12 month old white male patient with otitis media and upper respiratory tract infection who on 12/12/04 was vaccinated SC with a dose of MMR. Secondary concomitant vaccination on 12/12/04 included a dose of varicella virus vaccine live, diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid, influenza virus vaccine, HIB conjugate vaccine. Concomitant medication included prednisolone Na phosphate and budesonide. On 12/12/04, the patient experienced fever (from 101-103.7 degrees F), foam at mouth, 6 areas of redness and boil left thigh. The patient came to the office on 12/14/04 and was treated with cephalexin. On 12/17/04 the patient experienced foamy loose stool. On 12/20/04 the patient experienced roseola described as a rash all over. It was reported that the patient had recovered from the roseola, the boil, the areas of redness, the fever, and the foamy loose stools and the foaming at the mouth. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Thrombocytopenia
Clinical narrative: Initial and follow-up information was received from a consumer concerning her 5 year old daughter who in approximately OCT 2004 was vaccinated with MMR.  The patient was "recently" diagnosed with thrombocytopenia.  Unspecified medical attention was sought.  As of 19 JAN 2005 the patient's thrombocytopenia persisted.  The reporter felt that the event may be associated with MMR.  No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Malaise, Rash
Clinical narrative: Information has been received from an epidemiologist concerning an adult female healthcare worker with cystic fibrosis, who on 12/14/04 was vaccinated with a dose of MMR. On 12/23/04, the patient experienced malaise. on 12/27/04, she broke out with a rash and was diagnosed with rubella. The patient's outcome was unknown. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Age: 22.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from an approximately 22 year old male pharmacist technician who in approximately 1994 about 10 years ago was vaccinated with a dose of MMR. The patient had a titer test performed and it showed that he seroconverted for measles and rubella, but not for mumps. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Measles antibody negative, Pain
Clinical narrative: Information was received from a health professional concerning an approximately 35 year old female employee who was vaccinated with MMR.  It was reported that the patient failed to seroconvert for measles after 2 series of vaccinations.  It was also noted that the patient stated that the vaccination hurt.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information was requested. Follow-up information fromt he nurse confirmed that thepatient "has had 3 MMR vaccinations and still had not converted/showed immunity. Additional infromation is not expected.
Age: 1.0
Sex: F
Vaccine: FLU3, HBHEPB, MMR, VARCEL, FLU3, HBHEPB, MMR, VARCEL
Symptoms: Body temperature increased, Pallor, Pyrexia, Rash, Rash macular
Clinical narrative: Information has been received from a physician concerning a 12 month old female with no medical history or allergies, who on 12/31/04 was vaccinated with a 0.5ml dose of MMR (lot # 647279/0417P). Concomitant therapy included a dose of varicella virus vaccine live (lot # 646819/1065N). On 1/5/05, five days later, the patient developed a rash on her trunk and face. Unspecified medical attention was sought. A prescribed drug was required for the rash. No diagnostic studies were performed. It was reported that the patient's rash was still being treated with prescription drug treatment. No product quality complaint was involved. Additional information has been requested. Initial and follow-up information has been received from a physician and a certified medical assistant concerning a 12 month old female with no medical history or allergies, who on 31-DEC-2004 was vaccinated SC in the right lower extremity, at 3:30 pm, with a first 0.5 ml dose of MMR II (lot# 647279/0417P). On 31-DEC-2004, at 3:25 pm. the patient was also vaccinated IM in the left upper extremity with a third dose of COMVAX (lot# 648823/0240P) and vaccinated SC in the left lower extremity with the first dose of VARIVAX (lot# 646819/1065M). Other concomitant therapy included a second dose of FLUZONE (lot# U1533AA). On 06-JAN-2005, at 10:30 am, the patient developed a macular rash on her trunk and face with blanching and a fever of 101. A prescription drug was required for the rash. No diagnostic studies were performed. It was reported that the patient was treated with an unspecified prescription drug. The patient's outcome was unknown. No product quality complaint was involved. Additional information is not expected. This is a consolidation of two reports concerning the same patient. It has been determined that WAES#0501USA02720 is a duplicate of WAES#0501USA00745. Therefore, WAES#0501USA02720 will be deleted from our files and consolidated into WAES#0501USA00745.
Age: 1.0
Sex: F
Vaccine: FLU3, HBHEPB, MMR, VARCEL, FLU3, HBHEPB, MMR, VARCEL
Symptoms: Pyrexia, Rash macular
Clinical narrative: Information has been received from a physician concerning a 12 month old female with no medical history or allergies, who on 12/31/04 was vaccinated with a 0.5ml dose of MMR (lot # 647279/0417P). Concomitant therapy included a dose of varicella virus vaccine live (lot # 646819/1065N). On 1/5/05, five days later, the patient developed a rash on her trunk and face. Unspecified medical attention was sought. A prescribed drug was required for the rash. No diagnostic studies were performed. It was reported that the patient's rash was still being treated with prescription drug treatment. No product quality complaint was involved. Additional information has been requested. Initial and follow-up information has been received from a physician and a certified medical assistant concerning a 12 month old female with no medical history or allergies, who on 31-DEC-2004 was vaccinated SC in the right lower extremity, at 3:30 pm, with a first 0.5 ml dose of MMR II (lot# 647279/0417P). On 31-DEC-2004, at 3:25 pm. the patient was also vaccinated IM in the left upper extremity with a third dose of COMVAX (lot# 648823/0240P) and vaccinated SC in the left lower extremity with the first dose of VARIVAX (lot# 646819/1065M). Other concomitant therapy included a second dose of FLUZONE (lot# U1533AA). On 06-JAN-2005, at 10:30 am, the patient developed a macular rash on her trunk and face with blanching and a fever of 101. A prescription drug was required for the rash. No diagnostic studies were performed. It was reported that the patient was treated with an unspecified prescription drug. The patient's outcome was unknown. No product quality complaint was involved. Additional information is not expected. This is a consolidation of two reports concerning the same patient. It has been determined that WAES#0501USA02720 is a duplicate of WAES#0501USA00745. Therefore, WAES#0501USA02720 will be deleted from our files and consolidated into WAES#0501USA00745.
Age: 1.03
Sex: F
Vaccine: FLU3, HBHEPB, MMR, VARCEL, FLU3, HBHEPB, MMR, VARCEL
Symptoms: Body temperature increased, Pallor, Pyrexia, Rash, Rash macular
Clinical narrative: Information has been received from a certified medical assistant concerning a 12 month old female who on 12/31/2004, at 3:30pm, was vaccinated subcutaneously in the right lower extremity with the first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  On 12/31/2004, at 3:25pm, the patient was also vaccinated intramuscularly in the left upper extremity with a third dose of concomitant suspect therapy hib conj-hepatitis b vaccine, and vaccinated subcutaneously in the left lower extremity with the first doses of concomitant therapy included a second dose of influenza virus split virion 3v vaccine inactivated.  On 01/06/2005, at 10:30am, the patient developed a macular rash, with blanching and fever of 101.  Unspecified medical attention was sought.  The patient's outcome was not reported.  Additional information is not expected. This is follow-up to report (s) previously submitted on 5/27/2005. Information has been received from a certified medical assistant (CMA) concerning a 12 month ild female wo on 31-DEC-2004, at 3:30 p.m., was vaccinated SC in the right lower extremity with the first dose of MMR II (lot #647279/0417P). On 31-DEC-2004, at 3:25 p.m., the patient was also vaccinated IM in the left upper extremity with a third dose COMVAX vaccine (MSD) (lot #648823/0240P), and vaccinated SC in the left lower estremity with the first dose of VARIVAX vaccine live (Merck) (MSD) (lot # 646819/1065N). Other concomitant therapy included a second dose of FLUZONE (lot #U1533AA). On 06-JAN-2005, at 10:30 a.m., the patient developed a macular rash, with blanching and fever of 101. Unspecified medical attention was sought. The patient's outcome was not reported. Additional information is not expected. It has been determined that WAES#0501USA02720 is a duplicate of WAES#0501USA00745. Therefore, WAES#0501USA02720 will be deleted from our files and consolidated into WAES#0501USA00745.
Age: 1.03
Sex: F
Vaccine: FLU3, HBHEPB, MMR, VARCEL, FLU3, HBHEPB, MMR, VARCEL
Symptoms: Pyrexia, Rash macular
Clinical narrative: Information has been received from a certified medical assistant concerning a 12 month old female who on 12/31/2004, at 3:30pm, was vaccinated subcutaneously in the right lower extremity with the first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  On 12/31/2004, at 3:25pm, the patient was also vaccinated intramuscularly in the left upper extremity with a third dose of concomitant suspect therapy hib conj-hepatitis b vaccine, and vaccinated subcutaneously in the left lower extremity with the first doses of concomitant therapy included a second dose of influenza virus split virion 3v vaccine inactivated.  On 01/06/2005, at 10:30am, the patient developed a macular rash, with blanching and fever of 101.  Unspecified medical attention was sought.  The patient's outcome was not reported.  Additional information is not expected. This is follow-up to report (s) previously submitted on 5/27/2005. Information has been received from a certified medical assistant (CMA) concerning a 12 month ild female wo on 31-DEC-2004, at 3:30 p.m., was vaccinated SC in the right lower extremity with the first dose of MMR II (lot #647279/0417P). On 31-DEC-2004, at 3:25 p.m., the patient was also vaccinated IM in the left upper extremity with a third dose COMVAX vaccine (MSD) (lot #648823/0240P), and vaccinated SC in the left lower estremity with the first dose of VARIVAX vaccine live (Merck) (MSD) (lot # 646819/1065N). Other concomitant therapy included a second dose of FLUZONE (lot #U1533AA). On 06-JAN-2005, at 10:30 a.m., the patient developed a macular rash, with blanching and fever of 101. Unspecified medical attention was sought. The patient's outcome was not reported. Additional information is not expected. It has been determined that WAES#0501USA02720 is a duplicate of WAES#0501USA00745. Therefore, WAES#0501USA02720 will be deleted from our files and consolidated into WAES#0501USA00745.
Age: 1.01
Sex: M
Vaccine: MMR
Symptoms: Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male who in approximately 1/05 recently was vaccinated SC with a 0.5ml dose of MMR. Concomitant therapy included palivizumab. One day after vaccination, the patient broke out in a papular rash on the neck, ears, and body. The patient's outcome was unknown. Unspecified medical attention was sought. NO product quality complaint was involved. Follow up information indicated that on 11/23/04 the patient was vaccinated SC in the left arm with a first dose of MMR (lot #0963). On 11/28/04, the patient had a rash. The reporter did not feel that this was a reaction to MMR. On 12/30/04, the patient recovered. It was reported that the patient had a questionable amoxicillin (+) clavulanate potassium rash in November 2004. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Gastrointestinal disorder, Medication error
Clinical narrative: Information has been received from a physician's assistant who on 8/12/04 was vaccinating her son with a dose of MMR (lot # not available). The physician's assistant reported that she tried to vaccinate her son with MMR in her home. She had difficulty with the vaccination process and sprayed vaccine over the sink in her home. The physician assistant developed gastrointestinal problems which began on 8/23/04. Unspecified medical attention was sought. The physician's assistant also reported that her son developed gastrointestinal problems post vaccination with MMR (WAES0408USA01909). No additional information is expected.
Age: 4.0
Sex: M
Vaccine: DTP, IPV, MMR
Symptoms: Erythema, Oedema peripheral, Periorbital oedema, Swelling, Urticaria
Clinical narrative: Information has been received from a physician concerning a 4 year old white male with Asthma, an egg white allergy, and an allergy to amoxicillin who on 01/10/2005, at 16:00, was vaccinated in the right forearm with the first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant vaccinations on that same day and time included the third dose in the right forearm of poliovirus vaccine inactivated and the fourth dose in the left forearm of diphtheria toxoid pertussis vaccine, tetanus toxoid.  Illness at the time of vaccination included a mild cough and mild postnasal drip.  The physician reported that on 01/11/2005, the patient developed some swelling and redness in his left deltoid area.  The patient was noted to be afebrile.  Later that night and mostly on 01/12/2005 the patient developed hives all over his body.  On 01/13/2005, the patient presented to the doctor's office with hives from head to toe, periorbital edema and swollen feet.  There was positive swelling of the dorsum of both feet as well as facial swelling, mainly periorbital.  The patient was treated with diphenhydramine hcl, every 6 hours and a five day course of prednisolone Na phosphate.  On 01/14/2005, the patient recovered from his events.  There was no product quality complaint involved.  Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Balance disorder, Erythema, Lymphadenopathy, Muscular weakness, Pyrexia
Clinical narrative: Information has been received from an aunt concerning her 17 month old niece, with no reported medical history and no known drug allergies, who in December 2004, was vaccinated with a dose of measles virus vaccine live, mumps virus vaccine live rubella virus vaccine live (lot # 648474/0314P); route of administration unknown.  There was no concomitant medication.  Subsequently, a few days after vaccination in approximately December 2004, the patient developed a fever of 100.4 degrees, swelling of the lymph nodes between her legs, redness underneath her eye lids, weakness in her legs and loss of balance, tilting to her right side.  It was also reported that the patient sought unspecified medical attention and that she had not recovered at the time of the report.  There was no product quality complaint involved.  Additional information is not expected.
Age: 1.02
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Dyspnoea, Urticaria
Clinical narrative: Information has been received from a nurse practitioner concerning a 12 month old male child with allergies to cats and eggs who was vaccinated with measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included varicella virus vaccine live and Hib conj vaccine given during the same visit.  The mother of the patient reported to the nurse practitioner that the patient experienced hives and difficulty breathing.  The nurse practitioner reported that the patient sought medical attention but was not seen by a health care professional during this experience.  Subsequently, the patient recovered from hives and difficulty breathing.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician concerning 3 male patients who were vaccinated with doses of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live, and have tested positive for the mumps after showing undisclosed symptoms.  Unspecified medical attention was sought.  No product quality complaint was involved.
Age: 1.81
Sex: F
Vaccine: MMR
Symptoms: Infection, Rash erythematous, Rash morbilliform
Clinical narrative: Information has been received from a dentist concerning her 22 month old daughter, with no medical history, who on 01/07/2005 was vaccinated with a dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  There was no concomitant medication.  On 01/20/2005 the patient developed a measles like rash over all of her body.  It was also noted that she developed symptoms of the measles on 01/20/2005.  The patient's symptoms persisted.  Unspecified medical attention was sought.  No product quality complaint was involved.  Follow up information from a dentist indicated that on 01/20/2005 the patient had large spots on her arm, legs, and forehead.  There were raised dots, some as large as 50 cent pieces.  By the afternoon of the same day they resembled mosquito bites.  On 01/21/2005 all spots were gone.  The full rash had raised red dots that did not blanche on entire trunk, neck, ears, and alot on the face.  It was reported that the patient wore sunglasses for 2 days.  The rash disappeared completely by 01/27/2005.  It was noted that the patient had no fever.  Additional information is not expected.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Rash
Clinical narrative: Information has been received from a mother concerning her 7 year old daughter with no past medical history who on 11/03/1998 and on 09/13/2001 was vaccinated with a first and second dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  There was no concomitant medication.  It was reported that the patient now has either measles or chickenpox because she has bumps all over her body.  The mother reported that the physician not sure if patient had an allergic reaction to the vaccine or if she really has measles or chickenpox.  It was reported that the patient had blood drawn up and is currently waiting for the results of the test.  Unspecified medical attention was sought.  No product quality complaint involved.  The patient was considered to be not recovered.  Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a medical student concerning a 14 month old male who on 01/12/2005 was vaccinated with measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live subcutaneously.  There was no concomitant medication.  On 01/24/2005, the patient developed an erythematous, raised, urticarial rash on his body two weeks after vaccination.  The rash started on his back and spread to his abdomen, arms and legs.  Some of the lesions had a clear central head.  There was no rash on the palms of the hands or soles of the feet.  The patient was treated with diphenhydramine and the rash resolved the next day.  No product quality complaint involved.  No further information is expected.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Infection, Lymphadenopathy
Clinical narrative: Information has been received from a physician concerning a 6 year old white female patient with no known drug allergies who on 08/05/1999 and 08/13/2003 was vaccinated with a first and second dose, respectively, of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live and tested positive for mumps after showing undisclosed symptoms.  Unspecified medical attention was sought.  No product quality complaint was involved.  Follow up information indicated that the patient had a right swollen parotid on 01/12/2005.  Her serum amylase was 314 and MMR was noted.  The patient recovered on January 2005 and the experience is no longer being treated.  Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection, Lymphadenopathy
Clinical narrative: Information has been received from a physician concerning a 10 year old white male with no known drug allergies who was vaccinated subcutaneously with a first and second dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live, on 03/11/1996 (lot 614677/1427B) and 10/06/1998 (627678/1170H), respectively.  On 01/13/2005 the patient experienced swollen right parotid.  It was reported that the patient   tested positive for mumps.  His serum amylase was 105 and the physician reported MMR.  Unspecified medical attention was sought.  In January 2005 the patient recovered.  There was no product quality complaint involved.  No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Drug ineffective, Parotid gland enlargement
Clinical narrative: Information has been received from a physician concerning a 10 year old white male with an allergy to cefadroxil who was vaccinated SC with a first and second dose of MMR on 9/20/95 (lot # 615609/0621B) and 6/10/99 (lot # 630118/1977H), respectively. On 1/20/05, it was reported that the patient subsequently tested positive for the mumps. The physician reported that the patient had a swollen right parotid, his serum amylase was 844 and the physician reported +MMR. Unspecified medical attention was sought. In January 2005, the patient recovered. There was no product quality complaint involved. No further information is available.
Age: 1.19
Sex: M
Vaccine: MMR
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a registered nurse concerning a 14 month old white male who may be allergic to eggs, with no medical history who on 11/3/04 was vaccinated SC into the right leg with a first dose of MMR (lot # 646897/1173N). There was no illness at the time of vaccination. On 11/3/04, the patient developed localized swelling at the injection site. Subsequently, the patient recovered. No product quality complaint was involved. Further information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information was received from a nurse concerning a patient (age ad gender not reported) who was vaccinated three times with MMR.  It was reported that the patient had negative rubella titers which was considered vaccine failure.  Unspecified medical attention was sought.  Additional information was requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Pyrexia, Rash morbilliform
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who on 5/15/00 was vaccinated with his first dose of MMR. Post vaccination, the patient developed a measles like rash and prolonged fever. Unspecified medical attention was sought. A titer was drawn and the child seroconverted for measles and rubella, but not for mumps. Subsequently, the patient recovered. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: MEA, MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a physician concerning a 34 year old female who was vaccinated three times since her childhood with either MMR or measles vaccine.  The physician reported that at the time of this report the patient did not show immunity to measles.  The patient sought unspecified medical attention.  The patient had no symptoms.  Additional information has been requested.
Age: 1.16
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information was received from a physician concerning a 14 month old male with no medical history and no allergies who on 12 JAN 2005 was vaccinated with a first dose of MMR.  On 23 JAN 2005 the patient broke out in hives and was seen in the office on 24 JAN 2005.  The patient was treated with oral Benadryl.  Subsequently the patient had a follow-up visit and the hives had resolved.  Additional information has had requested.
Age: 30.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Initial and follow up information has been received from a physician and a health professional concerning a 34 year old male patient who on 7/29/99 was vaccinated with a first dose of MMR. A second vaccination with MMR was administered on 2/22/00. On 2/17/05, it was reported that the patient is now going to medical school and titer for mumps is negative. The patient's IgG test for mumps titer was 0.91. The physician reported that he will  plant to revaccinated patient. Follow up information provided by the doctor office indicated that the medical school students left for Guam for the next three years to attend school. No further information is available. There was no product quality complaint involved. Additional information is not expected.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Eye irritation, Medication error
Clinical narrative: Information has been received from a health professional concerning a female employee in her thirties, with no medical history, who on 2/22/05 was preparing a syringe with MMR and it splashed in her eyes. The patient's eyes were flushed with cool water and she was immediately seen by an eye doctor. It was reported that the patient's burning of the eyes persisted after 15 minutes of the incident. It was noted that there was no concomitant medication. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 45.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Information has been received from a registered nurse concerning a 45 year old male with babesiosis disease from an infected tick bite, Lyme's disease, and no known allergies who was vaccinated when he was a child with MMR. Concomitant therapy included azithromycin, cefuroxime axetil, and atovaquone. Since the patient had no written vaccine documentation, an antibody titer was drawn on 2/21/05. The range for the equivocal test was .91 to 1.09. The result was equivocal at .97 for rubeola. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 9.0
Sex: U
Vaccine: MMR
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician through a company representative concerning a 9 year old patient who was vaccinated at 15 months and 5 years of age with first and second doses of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  It was unknown if the patient was taking concomitant medication.  Subsequently the patient developed mumps at 9 years of age.  The patient sought unspecified medical attention.  The patient outcome is unknown.  There was no product quality complaint involved.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information was received from a nurse concerning a 4 year old male who on 01 MAR 2005 was vaccinated in the right arm with 0.5ml dose of MMR.  On 01 MAR 2005 immediately after vaccination the patient "broke out in hives at the injection site".  The patient was treated with oral Benadryl.  Subsequently on an unspecified date, the patient recovered from hives at the injection site.    The nurse requested a lot number check.  The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory.  The lot complies with the standards of the Center for Biologics Evaluation and Research and was release.  Therre was no product quality complaint involved.
Age: 15.0
Sex: M
Vaccine: MMR
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician through a company representative concerning a 15 year old male patient with a history of vaccination subcutaneously with 2 doses, 0.5ml, of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live, as a child.  On 03/02/2005 the patient came into the office with a case of the mumps.  Concomitant is unknown.  The patient outcome is unknown.  There was no product quality complaint involved.  Additional information has bee requested.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Injection site reaction, Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 15 month old patient who on 02/28/2005 was vaccinated subcutaneously in the left arm with a 0.5ml dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  On 02/28/2005, immediately after vaccination, the patient broke out in hives at the injection site.  The patient was treated with oral diphenhydramine hydrochloride.  Subsequently, on an unspecified date, the patient recovered from hives at the injection site.  The nurse requested lot number check.  The records of testing prior to release of this lot have been checked by quality assurance and found to be satisfactory.  The lot complies with the standards of the research center and was released.  There was no product quality complaint involved.  Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Injection site reaction, Urticaria
Clinical narrative: Information was received from a nurse concerning a 16 month old patient who on 28 FEB 2005 was vaccinated with 0.5 ml of MMR.  On 28 Feb 2005 immediately after vaccination the patient "broke out in hives at the injection site"   The patient was treated with oral Benadryl.  Subsequently on an unspecified date the patient recovered.  The nurse requested  lot number check.  The records of testing prior to release of this lot has been checked by quality assurance and found to be satisfactory  The lot complies with the standards of the center for biologics evaluation and research and was release.  There was no product quality complaint involved
Age: 41.0
Sex: F
Vaccine: DPP, MMR
Symptoms: Conjunctivitis, Lymphadenopathy, Pyrexia, Rash, Skin test positive
Clinical narrative: Information has been received from a nurse concerning a 41 year old female with tuberculin test positive (02/15/2005) who on 02/15/2005 was vaccinated subcutaneously with a 0.5ml dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included tuberculin purified protein derivative and diphtheria toxoid/tetanus toxoid.  5 to 7 days post vaccination, on approximately 02/20/2005, the patient developed fever, rash, swollen glands and conjunctivitis.  On approximately 02/25/2005, the patient had bumps on the back of her neck, lumphadenopathy.  On approximately 02/26/2005, the patient had a rash on her belly, arms and thighs.  On 03/04/2005, the patient was seen in the physicians office with a fine reticular rash which was fading, lymphadenopathy which was better, pink eye which was continued and fever was gone.  The patient was treated with sulfacetamide sodium eye drops.  The patient had also taken ibuprofen at home, but had discontinued use of ibuprofen as of 03/04/2005.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/27/2005.  Initial and follow up information has been received from a licensed visiting nurse and physician concerning a 41 year old female with tuberculin test positive (15-Feb-2005) and no other pre-existing allergies, birth defects or medical conditions reported.  On 15-FEB-2005 the patient was vaccinated subcutaneously in the right arm with a 0.5ml dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Concomitant therapy included tuberculin purified protein derivative and diphtheria toxoid/tetanus toxoid.  Five to seven days post-vaccination, on approximately 20-FEB-2005, the patient developed fever, rash, swollen glands and conjunctivitis.  On approximately 25-FEB-2005, the patient had bumps on the back of her neck, lumphadenopathy.  On approximately 26-FEB-2005, the patient had a rash on her belly, arms and thighs.  On 04-MAR-2005, the patient was seen in the physician's office with a fine reticular rash which was fading, lymphadenopathy which was better, pink eye which was continued and fever was gone.  The patient was treated with SULAMYD eye drops.  The patient had also taken ADVIL at home, but had discontinued use of ibuprofen as of 04-MAR-2005.  As of 15-MAR-2005, the patient had recovered from the events.  No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective, Infection, Swelling
Clinical narrative: Information has been received from a health professional concerning a 5 year old female who on 09/13/2004 was vaccinated with a first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Subsequently the patient experienced mumps.  It was reported that the patient was seen in the ER, but not hospitalized.  No laboratory diagnostic tests were done and no medications were given.  The patient recovered on an unspecified date.  There was no product quality complaint involved.  Follow up information from the health professional indicated that the patient's mother stated that the patient was given vaccine and within 24 hours her neck was swollen.
Age: 52.0
Sex: F
Vaccine: MMR
Symptoms: Rash macular, Rheumatoid arthritis
Clinical narrative: Information was received from a nurse concerning a 52 year old female with rheumatoid arthritis who on approximately 09 FEB 2005 was vaccinated with a dose of MMR.  There was no other vaccination at the same time.  Concomitant therapy included LEVAQUIN for rheumatoid arthritis.  On 06 MAR 2005, 26 days later, the patient developed a macular rash.  No treatment was suggested.  Unspecified medical attention was sought.  The outcome was reported as not recovered.  There was no product quality complaint.  Additional information was requested.
Age: 13.0
Sex: M
Vaccine: MMR
Symptoms: Viral infection
Clinical narrative: Information has been received from a medical assistant concerning her 13 yr old son who was vaccinated with a dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). On approx 09Mar05, the pt developed mumps and at the time of the report is currently in isolation in the hospital. Unspecified blood tests on approx 09Mar05 confirmed mumps. A product quality complaint was not involved. Mumps was considered to be an other important medical event. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 24 month old male patient with minor eustachian tube problems and no know drug allergies who on 04/24/2002 was vaccinated subcutaneously in the left arm with a 0.5ml first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine.  Post vaccination the patient experienced parotid swelling and fever.  The patient sought medical attention but it was reportedly unknown what treatment was recommended.  Subsequently, the patient recovered from parotid swelling and fever.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/27/2005. Information has been received from a physician concerning a 24 month old male patient with minor eustachian tube problems and no known allergies, who on 24-APR-2002 was vaccinated SC into the left arm wih a 0.5 ml first dose of MMR II (lot # 641723/0426M). There was no illness at the time of vaccination. On 01-MAY-2002 seven to eight days after vaccination, the patient experienced swollen glands behind his ears, and a fever. Unspecified medical attentionwas sought. No diagnostic laboratory tests were performed. It was noted that the patient was minitored by a surgeon and a pediatrician. No treatment or surgery was needed. The swollen glands lasted for several months. In July 2002, the patient recovered. no further information is expected.
Age: 1.0
Sex: F
Vaccine: HIBV, MMR
Symptoms: Abnormal behaviour, Pyrexia, Rash, Staring, Tremor
Clinical narrative: Information has been received from a physician via a company representative concerning a 12 month old female patient with no known allergies who on 03/04/2005 was vaccinated with a dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  On 03/10/2005 the patient seemed to shake when she was sleeping, her eyes appeared glassy and the child behave strangely.  The physician examined the patient and saw no symptoms that were described by the parent.  Subsequently, the patient recovered on 03/10/2005.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/27/2005. Initial and follow up information has been received from a physician via a company representative concerning a 12 month old female patient with no known allergies and no past medical history who on 01-MAR-2005 (previously reported as 04-MAR-2005) was vaccinated with a first dose of MMR II (lot #648482/0615P) into a site reported as "right." Concomitant vaccinationon 01-MAR-2005 included a fourth dose of ACTHIB (lot #UE394AA). There was no illness at the time of vaccination. According to the patient's grandmother on 10-MAR-2005 the patient seemed to shake when she was sleeping, her eyes appeared glassy and the child behaveed strangely with poor behavior. She had a fever and a rash also. The physician examined the patient and saw no symptoms that were described by the parent. Subsequently, the patient recovered on 10-MAR-2005. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: MMR
Symptoms: Pruritus
Clinical narrative: Information has been received from a licensed visiting nurse concerning her 20 year old daughter who about 3 years ago was vaccinated with a dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Within minutes of the vaccination, her daughter's whole arm began to itch.  Unspecified medical attention was sought.  She was treated with over the counter Benadryl.  It was reported that all symptoms resolved.  No additional information was available at the time of this report.  No product quality complaint was involved.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Injection site swelling
Clinical narrative: Information has been received from an office worker concerning a 4 year old female who on 03/11/2005 was vaccinated with measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  On an unspecified date, following immunization, the patient developed swelling around the joint area on the limb at the injection site.  It was reported that the patient sought unspecified medical attention.  At the time of this report the outcome of the event was unknown.  Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Eye irritation
Clinical narrative: Initial and follow up information has been received from a registered nurse and a nurse in the physician's office, concerning a 37 year old female who on an unspecified date received an accidental eye splash with the vaccine measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live as it was being prepared to be administered to her child.  It was reported that the poison control was contacted and an incident report was filled out.  The nurse considered the event to be non-serious and reported that the patient was fine, however, had some burning in her eye.  It was reported that the patient was administered an eye flush.  It was reported that the patient was instructed to call the doctor's office if she had any problems, however, at this time, the patient had not contacted the physicians office.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Arthritis, Injection site swelling, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 5 yr 3 month old male who on 22Mar05 was vaccinated with a dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 0771F). Subsequently the pt developed a rash with joint inflammation and fever. The pt was treated with diphenhydramine hydrochloride (Benadryl). The pt's status was reported as not recovered. No product quality complaint was involved. The reporter felt that the rash with joint inflammation and fever were other important medical events. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/27/2005.  Initial and follow-up information has been received from a physician and a health care worker concerning a 5 year old male patient with asthma and a history of pneumonia who on 22-MAR-2005 was vaccinated in the right thigh with a second dose of MMR II (Lot # unknown).  The health care worker reported that the next day (also reported as 23-MAY-2005), the patient developed a swollen knee, 2 cm below the injection site.  The reporter indicated that an allergic reaction to the vaccine was questionable.  It was reported that the patient had an upper respiratory tract infection post-pneumonia at the time of vaccination.  The patient was given TYLENOL for pain and told to rest and elevate the leg.  Three days later (also reported as 27-MAY-2005), the office contacted the family and it was reported that the swelling had subsided.  The patient was reported to be recovered.  Additional information is not expected.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Drug ineffective
Clinical narrative: Info has been received from an NP concerning a 32 year old female who was vaccinated with measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live. Subsequently, the pt "was not shown to be immune to the components based on a drawn titer". Unspecified medical attention was sought. No product complaint involved. Additional info has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Info has been received from a consumer concerning her sone with no allergies or drug reactions who was vaccinated with a dose of MMR. The reporter indicated that the pt had a rash associated with the vaccination (not further specified).  Additional info has been requested. The reporter also noted that the pt developed cellulitis and breathing difficulties after vaccination with a dose of varicella virus vaccine (WAES0503USA04939).
Age: 1.27
Sex: F
Vaccine: MMR
Symptoms: Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a 15 month old female who on 17-Mar-2005 was vaccinated with a dose of measles virus vaccine live (Endera-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot number 648661/0610P). On approximately 26-Mar-2005, nine days after vaccination the child developed a measles like rash and mild fever. At the time of this report no fever was present and the rash was resolving.  Additional information has been requested.
Age: 1.04
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Muscle twitching, Urticaria
Clinical narrative: Information has been received from a health professional concerning a 12 month old white male patient with no known allergies who on 17-Mar-2005 was vaccinated SC into the left thigh with a first dose of measles virus vaccine live (Endora-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot # 644844/0771P). Secondary concomitant therapy included a first SC dose of varicella virus vaccine live (lot # 648308/0276P) into the right thigh. It was reported that there was no illness at the time of vaccination. On 18-Mar-2005 the patient's mother called the office and reported that the patient had developed "white welts with red circles" on the back, face, abdomen and extremities. The patient had no fever. The physician advised the patient to take diphenhydramine hydrochloride (BENADRYL) 1 teaspoon po every 6 hours. According to the reporter the rash seemed worse and the child seemed to be quivering. The patient was examined in the emergency room on 19-Mar-2005 and had no fever, no respiratory symptoms and was diagnosed with urticaria. The patient was given diphenhydramine hydrochloride (BENADRIYL) 5mg every 4 to 6 hours as needed and was discharged home in good condition. It was reported that the patient had recovered.  Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Injection site hypersensitivity, Injection site pain, Pyrexia, Rash
Clinical narrative: Information has been received from a female health professional in her 40's who "reacts badly to tetanus", and who in 1996 was vaccinated with a dose of measles virus vaccine live (Endors-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). *On the second night post vaccination*, in 1996, the patient experienced pain in her deltoid, a circle, 4-5 inches in diameter, around the immunization site, a generalized rash over her entire body, and a fever of 103F. It was reported that the patient messed a week of work. Subsequently, the patient recovered. Medical attention was not sought. No product quality complaint was involved.  Additional information has been requested.